Bromodeoxyuridine-mediated radiosensitization in human glioma: The effect of concentration, duration, and fluoropyrimidine modulation

This publication has 20 references indexed in Scilit:

• The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Presidential address: Malignant glioma—A nemesis which requires clinical and basic investigation in radiation oncology
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas
  Journal of Neurosurgery, 1988
• Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
  Journal of Clinical Oncology, 1988
• Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs
  International Journal of Radiation Oncology*Biology*Physics, 1987
• S‐phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine
  International Journal of Cancer, 1986
• Modulation of 5-IODO-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines
  Biochemical Pharmacology, 1985
• The use of halogenated thymidine analogs as clinical radiosensitizers: Rationale, current status, and future prospects: Non-hypoxic cell sensitizers
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study
  Cancer, 1983
• GENETICS OF HUMAN CELL LINES
  The Journal of Experimental Medicine, 1960